Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 195.17 | 113.17 | 12.53 | 18.01 |
Depreciation/ Depletion | 53.30 | 57.36 | 131.04 | 87.29 |
Non- Cash Items | 71.46 | 75.41 | 94.62 | 92.06 |
Changesin Working Capital | -501.25 | -51.33 | -87.92 | -62.41 |
Cashfrom Operating Activities | -181.32 | 194.62 | 150.27 | 134.95 |
Capital Expenditures | -44.52 | -12.77 | -18.41 | -4.40 |
Other Investing Cash Flow Items Total | -59.80 | -0.60 | 23.19 | -5.78 |
Cashfrom Investing Activities | -104.32 | -13.37 | 4.77 | -10.17 |
Financing Cash Flow Items | 809.16 | -128.52 | -104.87 | -83.89 |
Issuance( Retirement)of Debt Net | -110.25 | -57.13 | -36.01 | -39.85 |
Cashfrom Financing Activities | 698.91 | -185.66 | -140.88 | -123.75 |
Net Changein Cash | 413.28 | -4.41 | 14.17 | 1.02 |
Cash Interest Paid | 126.05 | 128.52 | 104.87 | 83.89 |
Foreign Exchange Effects | - | - | - | -0.01 |
Cash Taxes Paid | - | - | - | -0.64 |
Ind-Swift Laboratories Dividend Ind-Swift Laboratories Bonus Ind-Swift Laboratories News Ind-Swift Laboratories AGM Ind-Swift Laboratories Rights Ind-Swift Laboratories Splits Ind-Swift Laboratories Board Meetings Ind-Swift Laboratories Key Metrics Ind-Swift Laboratories Shareholdings Ind-Swift Laboratories Profit Loss Ind-Swift Laboratories Balance Sheet Ind-Swift Laboratories Q1 Results Ind-Swift Laboratories Q2 Results Ind-Swift Laboratories Q3 Results Ind-Swift Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks